TRIL

Trillium Therapeutics Inc.
TRIL

Overview Fund Activity
Delisted

TRIL was delisted on the 16th of November, 2021.

Back to rankings

29 hedge funds and large institutions have $42.1M invested in Trillium Therapeutics Inc. in 2018 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 2 closing their positions.

Holders
29
Holders Change
+2
Holders Change %
+7.41%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
4
Increased
9
Reduced
6
Closed
2
Calls
$4K
Puts
$18K
Net Calls
-$14K
Net Calls Change
-$40K

Top Buyers

1
BBA
1
Baker Bros. Advisors
New York
$3.07M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$864K
3
Deutsche Bank
3
Deutsche Bank
Germany
$732K
4
Morgan Stanley
4
Morgan Stanley
New York
$1.71M
5
MCMC
5
Matrix Capital Management Company
New Hampshire
$13.7M

Top Sellers

1
NLVP
1
New Leaf Venture Partners
New York
$0
2
Victory Capital Management
2
Victory Capital Management
Texas
$0
3
AIC
3
AWM Investment Company
New York
$4.21M
4
Millennium Management
4
Millennium Management
New York
$82K
5
Royal Bank of Canada
5
Royal Bank of Canada
Ontario, Canada
$4K
Name Holding Trade Value Shares
Change 		Shares
Change %
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$4K -$3.85K -587 -49%
TRCT
27
Tower Research Capital (TRC)
New York
$3K -$1K -163 -25%
FDCDDQ
28
Federation des caisses Desjardins du Quebec
Quebec, Canada
$379 – – –
NLVP
29
New Leaf Venture Partners
New York
– -$2.91M -404,159 Closed
Victory Capital Management
30
Victory Capital Management
Texas
– -$2.09M -290,571 Closed
1
2